Showing results (461-470 of 537) with videos related to

Sort By:
Pageof 54
Scandinavian Journal of Rheumatology|April 22, 2020
Immunoglobulin A antibodies to oxidized collagen type II as a potential biomarker for the stratification of spondyloarthritis from rheumatoid arthritisC Vinci, M Infantino, S Raturi, et al.
Annals of the Rheumatic Diseases|February 19, 2017
A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritisGerd R Burmester, Iain B McInnes, Joel Kremer, et al.
Scientific Reports|February 8, 2019
S100A8 & S100A9: Alarmin mediated inflammation in tendinopathyLindsay A N Crowe, Michael McLean, Susan M Kitson, et al.
Annals of the Rheumatic Diseases|February 22, 2018
Lipid profile and effect of statin treatment in pooled phase II and phase III baricitinib studiesPeter C Taylor, Joel M Kremer, Paul Emery, et al.
Arthritis and Rheumatism|September 6, 2005
Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept studyBo Baslund, Niels Tvede, Bente Danneskiold-Samsoe, et al.
RMD Open|February 22, 2024
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITALLaura C Coates, Robert Landewé, Iain B McInnes, et al.
Theranostics|January 8, 2019
<i>In vivo</i> multiplex molecular imaging of vascular inflammation using surface-enhanced Raman spectroscopyJonathan Noonan, Steven M Asiala, Gianluca Grassia, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 1, 2023
Liposomal AntagomiR-155-5p Restores Anti-Inflammatory Macrophages and Improves Arthritis in Preclinical Models of Rheumatoid ArthritisAudrey Paoletti, Bineta Ly, Catherine Cailleau, et al.
Lancet (London, England)|December 10, 2022
Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)Joseph F Merola, Robert Landewé, Iain B McInnes, et al.
Annals of the Rheumatic Diseases|November 27, 2010
Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trialsMarleen G H van de Sande, Danielle M Gerlag, Beatrijs M Lodde, et al.
Pageof 54